Table 1.
Summary of findings table presenting the results of the GRADE synthesis and rating process. Table created with the GRADEpro Guideline Development Tool: GRADEpro GDT: GRADEpro Guideline Development Tool [Software]. McMaster University, 2020 (developed by Evidence Prime, Inc.). Available from gradepro.org. Table modified. Full information presented in Online Resource 4
| Certainty assessment | Certainty | ||||||
|---|---|---|---|---|---|---|---|
| No of studies | Study design | Risk of bias | Inconsistency | Indirectness | Imprecision | Other considerations | |
| Second primary malignancies | |||||||
| 8 | Observational studies | Serious | Not serious | Not serious | Serious | Dose–response gradient |
⨁◯◯◯ VERY LOW |
| Secondary hematologic malignancies | |||||||
| 3 | Observational studies | Not serious | Not serious | Not serious | Serious | Dose–response gradient |
⨁⨁◯◯ LOW |
| Dose response gradient | |||||||
| 8 | Observational studies | Serious | Not serious | Not serious | Serious | Dose–response gradient |
⨁◯◯◯ VERY LOW |